Investigational Drug Details
| Drug ID: | D214 |
| Drug Name: | LYS006 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | 118166566 |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | C1=CC(=CC=C1C2=NN(N=N2)CC(CC(=O)O)N)OC3=C(C=C(C=N3)Cl)F |
| Structure: |
|
| InChiKey: | ZEGMEJVULDALSH-UHFFFAOYSA-N |
| Molecular Weight: | 392.77 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 terminated (NCT04147195: Sponsor Decision) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0037 | NCT04147195 | Phase 2 | Recruiting | No Results Available | June 4, 2020 | February 28, 2022 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|